Stockreport

Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ... [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF Q : How is Taysha Gene Therapies considering endpoints for their trials given the heterogeneity of Rett syndrome? A : Sean Nolan, CEO, explained that they are consideri [Read more]